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Abstract
Myocardial infarction (MI) with non-obstructive coronary arteries (MINOCA) is an important clinical problem especially 
in the era of extensive utilization of coronary angiography in MI patients. Its pathophysiology is poorly understood which 
makes diagnostics and treatment of MINOCA challenging in everyday clinical practice. The aim of the study was to assess 
characteristics of MINOCA patients in Poland based on data from the Polish National ORPKI Registry. In 2016, 49,893 
patients with non-ST-segment elevation (NSTEMI) or ST-segment elevation (STEMI) myocardial infarction entered the 
ORPKI registry. MINOCA was defined as a non-obstructive coronary artery disease (CAD) and a lack of previous coronary 
revascularization. MINOCA was identified in 3924 (7.8%) patients and clinical presentation was more often NSTEMI than 
STEMI (MINOCA: 78 vs. 22%; obstructive CAD 51.1 vs. 48.9%; p < 0.0001). MINOCA patients were younger and more 
often females with significantly lower rates of diabetes, smoking, arterial hypertension, kidney disease, previous MI and 
previous stroke comparing to patients with obstructive CAD. Myocardial bridge was visualized in angiography more often 
in the MINOCA group (2.2 vs. 0.4%; p < 0.0001). Additional coronary assessment inducing fractional flow reserve, intravas-
cular ultrasound, optical coherence tomography was marginally (< 1%) used in both groups. Periprocedural mortality was 
lower in MINOCA group (0.13% vs. 0.95%; p < 0.0001). MINOCA patients represent a significant proportion of MI patients 
in Poland. Due to multiple potential causes, MINOCA should be considered rather as a working diagnosis after coronary 
angiography and further efforts should be taken to define the cause of MI in each individual patient.
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Highlights
• Myocardial infarction with non-obstructive coronary 
arteries (MINOCA) is an important clinical problem in 
the era of extensive usage of coronary angiography.
• Many of MINOCA causes are treatable, so additional 
diagnostics beyond coronary angiography is important 
for final diagnosis and treatment selection.
• In large-scale national registry patients with MINOCA 
represent a significant proportion of MI patients in 
Poland (7.8% of total myocardial infarction patients).
• Due to multiple potential causes, MINOCA should be 
considered rather as a working diagnosis after coronary 
angiography and further efforts should be taken to define 
the cause of MI in each individual patient.
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Introduction
Myocardial infarction (MI) with non-obstructive coronary 
arteries (MINOCA) is an important and common clini-
cal problem as according to current knowledge, almost 
every patient with the diagnosis of MI should be referred 
to coronary angiography. An invasive strategy is also a 
frequent approach in unclear cases, in which after ruling 
out the obstructive coronary artery disease (CAD) fur-
ther diagnostics should be applied. The pathophysiology 
of MINOCA is multifactorial and poorly understood with 
several proposed mechanisms. This makes diagnostics and 
treatment of MINOCA challenging in daily clinical prac-
tice. That is why the problem of MINOCA diagnostics was 
highlighted in the recent European Society of Cardiology 
Clinical Practice Guidelines on acute myocardial infarc-
tion in patients presenting with ST-segment elevation [1]. 
However, the problem of MINOCA was not explored in 
patients with MI in Poland. The purpose of the present 
analysis was to assess characteristics of MINOCA patients 
in Poland based on data from the Polish National Percuta-
neous Coronary Interventions Registry (ORPKI).
Methods
Data on patients with the diagnosis of ST-segment eleva-
tion (STEMI) or non-ST-segment elevation myocardial 
infarction (NSTEMI) included into the ORPKI between 
January and December 2016 (12 months) were analyzed. 
The ORPKI is a national electronic database operated by 
the Jagiellonian University Medical College in Krakow 
collecting data on all percutaneous procedures in interven-
tional cardiology performed in Poland [2, 3]. All medical 
procedures were performed according to current medical 
standards. MINOCA patients were identified if having the 
diagnosis of STEMI or NSTEMI with non-obstructive 
CAD visualized in angiography, and no previous coronary 
revascularization [4]. MINOCA patients’ characteristics 
were compared with obstructive CAD patients. Statistical 
analysis was based on standard descriptive statistics. Cat-
egorical variables were presented as percentages. Continu-
ous variables were expressed as median and interquartile 
range (IQR). Normality was assessed by the Kolmogo-
rov–Smirnoff–Lillifors (KLS) test. Equality of variances 
was assessed using the Levene’s test. Differences between 
groups were compared using the Student’s or the Welch’s 
t-test depending on the equality of variances for normally 
distributed variables. The Mann–Whitney U test was used 
for non-normally distributed continuous variables. Ordi-
nal variables were compared using the Cochran–Armitage 
test. Nominal variables were compared by the Pearson’s 
chi-squared test or by the Fisher’s exact test if 20% of 
cells had expected count < 5. The level of statistical sig-
nificance was set at p < 0.05. All analyses were carried 
out with JMP®, Version 12.2.0 (SAS Institute Inc., Cary, 
NC, USA).
Results
In 2016, 49,893 patients with STEMI or NSTEMI entered 
the ORPKI registry. MINOCA was identified in 3924 
(7.8%) patients (Fig. 1). Among these patients, NSTEMI 
was more frequent than STEMI. Time from pain onset 
to first medical contact and from contact to angiogra-
phy was longer in the MINOCA group (median 240 vs. 
180 min; 330 vs. 145 min; respectively; p < 0.0001 for 
both). Patients with MINOCA were younger and more 
often women with a lower rate of CAD risk factors com-
paring to patients with obstructive CAD. Heart failure 
symptoms (Killip class > 1) and cardiac arrest before angi-
ography were less frequent in MINOCA patients than in 
the obstructive CAD group. MINOCA patients were less 
likely to receive antiplatelet and antithrombotic treatment 
before angiography. Additional physiological assessment 
and intravascular imaging was marginally (< 1%) used 
in both groups. Myocardial bridges and coronary fistu-
las were more frequent in the MINOCA group (Table 1). 
Periprocedural mortality was lower in MINOCA group 
(0.13% vs. 0.95%; p < 0.0001).
Fig. 1  Study cohort. Patients with myocardial infarction enrolled into 
the ORPKI registry in 2016
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Discussion
In the current analysis of the large-scale national database, 
we showed that MINOCA patients represent a significant 
proportion of MI patients referred to invasive assessment in 
Poland. We found MINOCA in about 8% of patients which 
is similar to the recently published report from SWEDE-
HEART Registry (about 8%) as well as a meta-analysis of 
clinical studies (about 6%) [5, 6].
Importantly, MINOCA is just an initial and general diag-
nosis which does not describe underlying pathophysiology. 
The potential pathophysiological mechanisms of clinical 
scenario when MI may be diagnosed according to the defi-
nition but there is a lack of the obstructive coronary artery 
disease are quite complex. These include both coronary and 
non-coronary pathologies. The coronary causes comprise 
of several different mechanisms. Thromboembolism may be 
an underlying pathological factor by itself or may be caused 
by plaque rupture or coronary spasm. This includes also 
thrombotic disorders (hereditary or acquire) [6]. Plaque dis-
ruption may be caused by erosion, ulceration, plaque rup-
ture, and intraplaque hemorrhage. Coronary artery spasm 
may be present not only due to endogenous causes but may 
be provoked by exogenous substances like cocaine [7, 8]. 
Non-coronary etiologies are also frequent in MINOCA 
patients. It is important to recognize well-defined diseases 
with described etiopathologies like myocarditis, pulmonary 
embolism or Takotsubo cardiomyopathy in patients initially 
described as MINOCA. Importantly, some of those causes 
are treatable, so well planned diagnostics seems to be crucial 
Table 1  Characteristics of 
studied groups
STEMI ST-segment elevation myocardial infarction, NSTEMI non-ST-segment elevation myocardial infarc-
tion, MI myocardial infarction, COPD chronic obstructive pulmonary disease, ASA acetylsalicylic acid, 
FFR fractional flow reserve, IVUS intravascular ultrasound, OCT optical coherence tomography
MINOCA (n = 3924) Obstructive CAD 
(n = 45,969)
p-value
Type of MI at presentation < 0.0001
STEMI (%) 22 48.9
NSTEMI (%) 78 51.1
Age [years, median (25th–75th percentile)] 65.00 (55.00;75.00) 67.00 (59.00;76.00) < 0.0001
Female (%) 52.0 32.9 < 0.0001
Diabetes mellitus (%) 13.1 22.2 < 0.0001
Smoking (%) 15.1 25.2 < 0.0001
Arterial hypertension (%) 56.4 64.3 < 0.0001
Chronic kidney disease (%) 4.4 5.9 < 0.0001
Previous stroke (%) 2.7 3.7 0.0014
Previous MI (%) 4.4 19.2 < 0.0001
COPD (%) 3.0 2.9 0.7
Killip class on admission < 0.0001
 I (%) 93.8 86.2
 II (%) 4.0 8.3
 III (%) 1.2 2.7
 IV (%) 1.0 2.8
Cardiac arrest before angiography (%) 0.13 0.54 < 0.001
ASA before angiography (%) 53.7 63.4 < 0.0001
Unfractionated heparin before angiography (%) 30.3 39.2 < 0.0001
P2Y12 inhibitor before angiography < 0.0001
 Clopidogrel (%) 36.8 46.2
 Ticagrelor (%) 1.1 1.8
 Prasugrel (%) 0.03 0.2
Additional coronary artery assessment
 FFR (%) 0.38 0.08 < 0.0001
 IVUS (%) 0.11 0.13 0.8
 OCT (%) 0.08 0.02 0.06
Myocardial bridge (%) 2.2 0.36 < 0.0001
Coronary fistulas (%) 0.18 0.03 < 0.001
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for the final diagnosis, treatment selection and outcome of 
these patients. According to 2017 European Society of Car-
diology Clinical Practice Guidelines on STEMI, failure to 
identify the underlying cause may result in inadequate and 
inappropriate therapy in MINOCA patients [1]. The diag-
nostic algorithm based on suspected diagnosis and corre-
sponding diagnostics modalities (non-invasive and invasive) 
was proposed. This includes myocarditis (with echocardi-
ography, cardiac magnetic resonance and endomyocardial 
biopsy), coronary epicardial/microvascular etiology (with 
intravascular ultrasound (IVUS), ergonovine/acetylocholine 
test, pressure/doppler wire), myocardial disease (with echo-
cardiography and cardiac magnetic resonance), pulmonary 
embolism (with D-dimer, CT scan, thrombophilia screening) 
and type 2 MI (with extracardiac investigation) [1]. In the 
individual patients’ data meta-analysis of MINOCA patients 
diagnosed with cardiac magnetic resonance one-third of 
patients had myocarditis, whereas 21% had infarction in 
delayed enhancement imaging [9]. Intracoronary imaging is 
important in selected cases since plaque rupture, ulceration, 
erosion or intraplaque hemorrhage are rarely visible in angi-
ography in non-obstructive CAD. Reynolds et al. showed 
that plaque disruption confirmed by IVUS was observed 
in 38% of women with MINOCA. Interestingly, in some 
cases, plaque rupture was identified by IVUS even in angio-
graphically normal-appearing segments [10]. In addition, in 
patients with MINOCA invasive coronary provocative tests 
may be considered. Montone et al. showed acetylcholine 
and ergonovine tests to be safe in patients with MINOCA 
and suspected coronary vasomotor abnormalities. Moreover, 
test results correlated with clinical symptoms and outcome 
in follow-up [11]. In the meta-analysis of MINOCA studies, 
coronary artery spasm was inducible in 27% of patients [6]. 
In our analysis (patients undergoing coronary angiography 
in the year 2016) additional invasive imaging during coro-
nary angiography was marginally used. However, the current 
upgrade of the reimbursement program in Poland should 
solve this diagnostics limitation.
In line with previous reports, we found MINOCA patients 
to be younger, rather with an initial diagnosis of NSTEMI 
than STEMI and to be more often female comparing to 
patients with obstructive CAD. Our analysis also showed 
that MINOCA patients had a lower risk profile concern-
ing other CAD risk factors. However, in meta-analysis of 
MINOCA studies there was no significant difference in arte-
rial hypertension, diabetes mellitus, smoking, and family 
history of CAD comparing to obstructive CAD patients [6].
Patients with MINOCA have lower mortality comparing 
to obstructive CAD patients with MI in 12-month follow-
up. However, in-hospital mortality of about 1% and 3.5% 
at 12-month is still high especially as compared to stable 
non-MI patients with normal coronaries in angiography 
[6]. This underlines the need for precise diagnosis and 
dedicated treatment of MINOCA patients. In our analysis, 
only periprocedural mortality data were available with sig-
nificantly lower rates found in MINOCA comparing to MI 
patients with obstructive CAD.
Presented analysis has several limitations. Angiograms 
were assessed locally by operators, and not by an independ-
ent image analysis core laboratory. The ORPKI for the 
moment does not collect data beyond the cathlab. So, it was 
impossible to assess further diagnostics done during hospi-
talization and after discharge and to analyze data according 
to final diagnosis as well as provide event rates at follow-
up. In addition, there is a potential bias from unmeasured 
confounding factors not included in this analysis. Despite 
all these limitations our study reflects the outcome of a 
“real-world”. Thus, data could be extrapolated to the gen-
eral population.
Conclusions
Patients with MINOCA represent a significant proportion 
of MI patients in Poland. Due to multiple potential causes, 
MINOCA should be considered as a working diagnosis after 
coronary angiography and further efforts should be taken to 
define the cause of MI in each patient.
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